Alora (estradiol)
/ AbbVie
- LARVOL DELTA
Home
Next
Prev
1 to 14
Of
14
Go to page
1
August 29, 2026
Prevalence and Outcomes of Hormone Therapy Use Among Menopausal Women With Inflammatory Bowel Disease
(ACG 2026)
- "However, patients with CD prescribed systemic HT had higher oral prednisone use, while osteoporosis/fracture outcomes were lower among patients receiving systemic HT. Figure: 1-Systemic non-transdermal HRT included oral estradiol, conjugated estrogens, esterified estrogens, synthetic conjugated estrogens A and B, oral progesterone, oral medroxyprogesterone, conjugated estrogens/bazedoxifene (Duavee), estradiol acetate vaginal ring (Femring), and norethindrone acetate/ethinyl estradiol (Femhrt). 2-Systemic transdermal HRT included estradiol/norethindrone acetate transdermal patch (CombiPatch), estradiol/levonorgestrel transdermal patch (Climara Pro), estradiol transdermal patches (Alora, Climara, Dotti, Estraderm, Lyllana, Minivelle, Vivelle-Dot), estradiol transdermal gel (EstroGel, Divigel), and estradiol transdermal spray (Evamist). 3-Local estrogen therapy included low-dose vaginal estradiol formulations (Estring, Imvexxy, Vagifem, and Yuvafem) and vaginal conjugated..."
Clinical • Cardiovascular • Coronary Artery Disease • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Heart Failure • Hematological Disorders • Immunology • Inflammation • Inflammatory Bowel Disease • Musculoskeletal Diseases • Orthopedics • Osteoporosis • Pulmonary Embolism • Respiratory Diseases • Ulcerative Colitis
April 02, 2025
A new species of the genus Alora H. Adams, 1861 (Epitonioidea: Epitoniidae) from the bathyal Zone of the Western Atlantic.
(PubMed, Zootaxa)
- No abstract available
Journal
May 03, 2024
"Alora Centres": youth-led model for accelerating HIV testing and treatment among adolescents, Mizoram India
(AIDS 2024)
- "Engagement and ownership helped in reaching non-Key Population in Mizoram and enabled youth to talk freely about HIV. The successful implementation was shared with stakeholders in Mizoram and other states to replicate Alora as a person-centric model within universities for awareness; access to integrated HIV and other health services."
Cardiovascular • Hepatology • Human Immunodeficiency Virus • Hypertension • Infectious Disease • Inflammation
March 14, 2023
"$ACRX Divests FDA Approved Pain-Management Drug Dsuvia to Alora Pharma"
(,@BioStocks)
FDA event • Pain
March 14, 2023
"$ACRX AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals https://t.co/PuYnjjSLxb"
(,@stock_titan)
March 29, 2022
Alora Pharmaceuticals Executive Leadership Meet and Greet Reception
(AAN 2022)
- "Description: Meet and greet with the CEO of Alora/Avion Pharmaceuticals, the head of business development, as well as the chief scientific officer for a reception to introduce the company to the neurology space."
October 16, 2021
"Alora,Spain my Dad has lived here for nearly 20 years ..it’s very beautiful"
(,@james80_)
August 30, 2021
"$OSMT Osmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLC https://t.co/NN0TxH7F4V"
(,@stock_titan)
May 01, 2021
"2/ Marcela Ot'alora, Michael Mithoefer, Martin A. Lee, Casey Hardison, Andrew Weil, Bruce K. Alexander, Android Jones, Jay Stevens, Earth & Fire Erowids etc.? Very imperfect, a lot of people in who just seek profits."
(,@PeaceGuard4)
September 23, 2020
Drugs for menopausal symptoms.
(PubMed, Med Lett Drugs Ther)
- No abstract available
Journal
June 12, 2020
".@reuterspictures capture the Caminito del Rey (The King's Little Pathway) in El Chorro-Alora, near Malaga, Spain. It has been dubbed by many as the world's scariest pathway"
(,@Reuters)
April 15, 2014
A randomized Phase II study comparing treatment combinatons of Fulvestrant and AZD2014, Fulvestrant and Everolimus or Fulvestrant alone for patients with advanced or metastatic breast cancer.
(clinicaltrialsregister.eu)
- P2; N=240; Ongoing; Sponsor: Queen Mary, University of London; Phase classification: P=N/A -> P2
Phase classification • Biosimilar • Breast Cancer • Oncology • Triple Negative Breast Cancer
August 06, 2019
Estradiol/progesterone (Bijuva) for menopausal vasomotor symptoms.
(PubMed, Med Lett Drugs Ther)
- No abstract available.
Journal
August 06, 2019
Colorectal cancer screening.
(PubMed, Med Lett Drugs Ther)
- No abstract available.
Journal
1 to 14
Of
14
Go to page
1